MetLife, Inc. MET recently teamed up with the international health solutions provider for the Blue Cross Blue Shield companies, GeoBlue, to introduce Globaline. GeoBlue is supported by 15 Blue Cross Blue Shield companies and Bupa. Being an expatriate benefits solution, Globaline has been devised with the collective expertise of two global benefits leaders and combines health and ancillary insurance under a single roof. While medical, dental, vision, prescription, wellness, an international employee assistance program, and political and natural disaster assistance services of GeoBlue form a part of the newly launched solution, MetLife Worldwide Benefits' life, accidental death & dismemberment, and long-term disability insurance products have been included in it. These MetLife services are offered as part of the Group Benefits business. Services related to grief counseling, will preparation, digital estate planning and estate resolution are also provided with the newly launched solution. Therefore, Globaline is a comprehensive plan crafted for ease of implementation and management for providing medical and ancillary coverage to expatriates, a term used for persons residing out of their country of citizenship. A unified proposal for the entire coverage suite and a single point of contact for all services, from account servicing to implementation, enrollment and renewal, highlights the lucrativeness of the newly launched solution. Available for quotes now, Globaline can be availed by groups with effective or renewal dates beginning Jan 1, 2025. The recent collaboration with GeoBlue will enable MetLife customers to reap the benefits of the extensive global health capabilities and medical networks of the former. Also, MET will get access to the Blue Cross and Blue Shield networks in the United States and globally through the tie-up, which in turn, may serve as a means for MET to gain more customers. Expatriate medical coverage is essential for ensuring that expatriates have access to quality healthcare globally, thereby protecting them from significant financial burdens due to unexpected medical expenses. This coverage provides peace of mind, enabling expatriates to focus on their work and personal life. It also ensures compliance with local regulations. Therefore, Globaline seems to perfectly capitalize on the solid demand for expatriate benefits solutions. Shares of MetLife have gained 29.9% in the past year compared with the industry’s 25.8% growth. MET currently carries a Zacks Rank #3 (Hold). Zacks Investment Research Image Source: Zacks Investment Research Stocks to Consider Some better-ranked stocks in the insurance space are Reinsurance Group of America, Incorporated RGA, NMI Holdings, Inc. NMIH and RLI Corp. RLI. While Reinsurance Group sports a Zacks Rank #1 (Strong Buy), NMI and RLI carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Reinsurance Group’s earnings surpassed estimates in each of the last four quarters, the average surprise being 19.48%. The Zacks Consensus Estimate for RGA’s 2024 earnings indicates an improvement of 5.3% from the year-ago reported figure while the same for revenues implies growth of 12.9%. The consensus mark for RGA’s earnings has moved 1.4% north in the past 30 days. The bottom line of NMI outpaced earnings estimates in each of the last four quarters, the average surprise being 8.60%. The Zacks Consensus Estimate for NMIH’s 2024 earnings indicates an improvement of 10.7% from the year-ago reported figure while the same for revenues implies growth of 11.1%. The consensus mark for NMIH’s earnings has moved 4.9% north in the past 60 days. RLI’s earnings surpassed estimates in three of the trailing four quarters and missed the mark once, the average surprise being 132.39%. The Zacks Consensus Estimate for RLI’s 2024 earnings indicates an improvement of 18.4% from the year-ago reported figure while the same for revenues implies growth of 15.6%. The consensus mark for RLI’s earnings has moved 1.9% north in the past 60 days. Shares of Reinsurance Group, NMI and RLI have gained 45.2%, 31.5% and 2.9%, respectively, in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report RLI Corp. (RLI):Free Stock Analysis Report MetLife, Inc. (MET):Free Stock Analysis Report Reinsurance Group of America, Incorporated (RGA):Free Stock Analysis Report NMI Holdings Inc (NMIH):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
MetLife (MET), GeoBlue Unveil Globaline for Expatriate Benefits
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...